CA

Nymox Pharmaceutical Corporation


USPTO Granted Patents = 8

% Expired Patents = 12.5

Trademarks = 1

Forward Citations = 300

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Paul A Averback (8 out of 41 patents)

silverMedal Jack Gemmell (5 out of 11 patents)

bronzeMedal Judith Fitzpatrick (1 out of 17 patents)

4.  Maggie Focht (1 out of 1 patent)

5.  Riza Bibiano (1 out of 1 patent)


8 patents:

Nymox Pharmaceutical Corporation is a biopharmaceutical company focused on the research and development of novel therapeutics for a variety of medical conditions. The company's lead product is Fexapotide Triflutate, a treatment for enlarged prostate, which is currently in late-stage clinical trials. Nymox is also exploring other potential therapeutic applications for their proprietary technology. With a commitment to innovation and improving patient outcomes, Nymox is dedicated to bringing new and effective treatments to market.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

8 Patents

#195 in

#1,876 in Canada

CA
CA
Forward Citations = 300

5 inventors:

Please report any incorrect information to [email protected]
Loading…